Skip to main content
. 2015 Oct 14;15:693. doi: 10.1186/s12885-015-1716-9

Fig. 2.

Fig. 2

Progression-free survival for the capecitabine plus paclitaxel arm (CP, solid line) and capecitabine plus cisplatin arm (CC, dotted line)